Delivery Order SPE2DB20D3303-SPE2DB25FA0HX

Award Date 6/17/25
Potential Completion Date 7/10/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit BOTOX vials, with a ceiling value of $1,709.60 and a performance period through July 2, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of Botox. The contract is a firm-fixed-price delivery order with a ceiling value of $13,971.12 and an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-unit vials of BOTOX with a ceiling value of $8,613.60. The contract is a Firm Fixed Price, non-set-aside award with a period of performance through July 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...
This is a Delivery Order federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 100-unit vials of the medication Botox, with a ceiling value of $1,722.72 and a performance period through July 3, 2025. The contract is designated as a Firm Fixed Price, non-set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 100-unit vials of Botox. The contract has a firm fixed price of $90,442.80 and a period of performance ending on July 10, 2025. The contract is not set-aside and was openly competed. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-unit vials of the medication BOTOX, with a ceiling value of $4,306.80 and a completion date of June 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of 200-unit Botox vials. The $24,788.91 firm fixed-price contract has a completion date of June 17, 2025. The contract is not set aside and provides medical supplies to support federal agencies, including the Defense Health Agency and U.S. Coast Guard. Amerisourcebergen holds a larger $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,564.37 firm fixed price contract is for the delivery of 200 unit vials of BOTOX. The contract has an ultimate completion date of June 26, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 200 unit vials of BOTOX. The $2,564.37 firm fixed-price contract has a completion date of June 25, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside. The company holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 200-unit vials of Botox. The fixed-price contract has a ceiling value of $41,029.92 and a period of performance through June 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB25FA0HX
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of Botox. The contract has a ceiling value of $20,514.96 and a completion date of July 10, 2025. It is a firm-fixed-price contract and is not set aside for any socioeconomic program.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/16/25, 9:47 AM